VAXIGRIPTETRA susp inj 2025/2026 ser pré 0.5 ml
7680664270310
CH-66427
J07BB02
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
haemagglutininum influenzae A (H1N1)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum influenzae A (H3N2)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum influenzae B
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum influenzae B
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
natrii chloridum
|
- | Substance | HNIDK |
|
kalii chloridum
|
- | Substance | HNIDK |
|
dinatrii phosphas dihydricus
|
- | Substance | HNIDK |
|
kalii dihydrogenophosphas
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
1.72 MG | Substance | HBESI |
|
kalium
|
0.08 MG | Substance | HBESI |
|
formaldehydum
|
- | Substance | RESI |
|
octoxinolum-9
|
- | Substance | RESI |
|
neomycinum
|
- | Substance | RESI |
|
ovalbuminum
|
- | Substance | RESI |
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 66427
- Drug name
- VaxigripTetra, Suspension pour injection dans une seringue pré-remplie
- Galenic form
- SUPA
- ATC Code
- J07BB02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 12/06/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VAXIGRIPTETRA susp inj 15 µg 1 pce
- Description (DE)
- VAXIGRIPTETRA Inj Susp 15 µg 1 Stk
- Market launch
- 11/04/2025
- Narcotic (BTM)
- No